What is holding pharma back?

We ask the experts at Pharmageddon 2024

We’re on a mission to help pharmaceutical communications achieve their potential. To do this, it’s key for us as an agency to understand the obstacles you’re facing. Watch to see what we’ve discovered at Pharmageddon 2024.

Watch the videos now

Emma Vitalini, Amgen
Are we holding ourselves back? Emma thinks we are – that we tell ourselves we can’t, and let our fear of trying something new prevent progress.
Nina Fyhn, Sanofi
“I think it’s the people. Including myself…” Nina believes that we in pharma too often focus on negativity. Do you agree?
Carlos Eid, Novartis
Is it time to say goodbye to silos? Carlos says breaking silos and bringing everyone’s expertise closer is a change we should all make, with huge potential to drive bigger picture thinking.
Dr. Azmain Chowdhury, Clinical Creator
“If you can’t beat them, join them.” Clinician Creator Dr. Azmain is set on improving the landscape of health influencing with his brand of evidence-based ‘edu-tainment’.
Almudena Fraga, Lundbeck
According to Almudena, there is no single answer. But the “very process-based” nature of pharma means not always keeping up with the change happening around us.
Alex Collins, Gilead
Plenty of data, but not enough follow-through. Alex says pharma’s insular thinking means that gathering data has become a tick-box exercise that doesn’t translate into better work.
Gudula Petersen, Grünenthal
Gudula thinks we need to start listening more to patients – and from the very beginning. But how do we navigate the compliance and ethics?
James Harper, 28b
“In football, you have defence and attack etc., but they operate together as a team.” James talks about how isolated ways of working stop pharma being truly effective.